*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : AU7357560
CHEMICAL NAME : Adenosine, 2-chloro-2'-deoxy-
CAS REGISTRY NUMBER : 4291-63-8
BEILSTEIN REFERENCE NO. : 0624220
LAST UPDATED : 199807
DATA ITEMS CITED : 5
MOLECULAR FORMULA : C10-H12-Cl-N5-O3
MOLECULAR WEIGHT : 285.72
COMPOUND DESCRIPTOR : Drug
Mutagen
Human
SYNONYMS/TRADE NAMES :
* 2-Chloro-2'-deoxyadenosine
* Cladribine
* Leustatin
* RWJ 26251
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Human - man
DOSE/DURATION : 700 ug/kg/7D-C
TOXIC EFFECTS :
Skin and Appendages - dermatitis, other (after systemic exposure)
REFERENCE :
AJHEDD American Journal of Hematology. (John Wiley & Sons, 605 Third
Avenue, New York, NY 10158) V.1- 1976- Volume(issue)/page/year:
53,209,1996
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 150 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
LELYEA Leukemia and Lymphoma. (Harwood Academic Publishers GmbH c/o STBS
Ltd., POB 90 Reading, Berks, RG1 8JL, UK) V.1- 1989-
Volume(issue)/page/year: 5,1,1991
** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 100 mg/kg/5D-I
TOXIC EFFECTS :
Related to Chronic Data - death
REFERENCE :
LELYEA Leukemia and Lymphoma. (Harwood Academic Publishers GmbH c/o STBS
Ltd., POB 90 Reading, Berks, RG1 8JL, UK) V.1- 1989-
Volume(issue)/page/year: 5,1,1991
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Primate - monkey
DOSE/DURATION : 7 mg/kg/7D-C
TOXIC EFFECTS :
Gastrointestinal - hypermotility, diarrhea
Blood - granulocytopenia
REFERENCE :
LELYEA Leukemia and Lymphoma. (Harwood Academic Publishers GmbH c/o STBS
Ltd., POB 90 Reading, Berks, RG1 8JL, UK) V.1- 1989-
Volume(issue)/page/year: 5,1,1991
** MUTATION DATA **
TYPE OF TEST : DNA inhibition
TEST SYSTEM : Human Lymphocyte
DOSE/DURATION : 16 nmol/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
46,2362,1986
*** END OF RECORD ***
|
|
|
| ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| | NAME | CAS |
|
Acridine, 9-amino-2-methyl-
| 23045-12-7 |
|
Adenosine,5'-((L-3-amino-3-carboxypropyl)methylsulfonio)-5'-deoxy-, hydrogen sulfate, p-toluenesulfonate
| 23045-12-7 |
|
Adenosine,5'-((3-amino-3-carboxypropyl)methylsulfonio)-5'-deoxy-, hydroxide, inner salt, (S)-,4-methylbenzenesulfonate sulfate (1:2:2) (salt)
| 58994-55-1 |
|
Adenosine,5'-((L-3-amino-3-carboxypropyl)methylsulfonio)-5'-deoxy-, hydroxide, inner salt
| 29908-03-0 |
|
Adenosine,5'-((3-amino-3-carboxypropyl)methylsulfonio)-5'-deoxy-, (S)-, salt with 4-methylbenzenesulfonic acid,sulfate (salt) (1:1:2)
| 97540-22-2 |
|
Adenosine,5'-((L-3-amino-3-carboxypropyl)methylsulfonio)-5'-deoxy-, p-toluenesulfonate, sulfate (salt)
| 97540-22-2 |
|
Adenosine, 3'-amino-3'-deoxy-
| 2504-55-4 |
|
Adenosine, 3'-amino-3'-deoxy-N,N-dimethyl-
| 58-60-6 |
|
Adenosine, 3'-amino-3'-deoxy-, 1-oxide
| 94714-49-5 |
|
Adenosine,3'-(alpha-amino-p-methoxyhydrocinnamamido)-3'-deoxy-N,N-dimethyl-, L-
| 53-79-2 |
|
Adenosine,3'-((2-amino-3-(4-methoxyphenyl)-1-oxopropyl)amino)-3'-deoxy-N,N-dimethyl-, Dihydrochloride, (S)-
| 58-58-2 |
|
Acridine, 9-amino-3-methyl-
| 23045-13-8 |
|
Adenosine,5'-(5-amino-6-oxo-2-piperidinyl)-5'-deoxy-, (2S-cis)-delta-lactam
| 67214-43-1 |
|
Adenosine, 2-bromo-2'-deoxy-
| 89178-21-2 |
|
Adenosine, N-(2-(5-bromo-1H-imidazol-4-yl)ethyl)-
| 89178-21-2 |
|
Adenosine, N-(2-(5-bromo-1H-indol-3-yl)ethyl)-
| 89178-21-2 |
|
Adenosine, N-(2-(5-carboxyethyl-1H-indol-3-yl)ethyl)-
| 89178-21-2 |
|
Adenosine, N-(2-(5-carboxy-1H-imidazol-4-yl)ethyl)-
| 89178-21-2 |
|
Adenosine, N-(2-(5-carboxy-1H-indol-3-yl)ethyl)-
| 89178-21-2 |
|
Adenosine,N-(2-(5-carboxymethyl-1H-imidazol-4-yl)ethyl)-
| 89178-21-2 |
|
Adenosine, 5'-chloro-5'-deoxy-
| 892-48-8 |
|
Adenosine, 2-chloro-
| 146-77-0 |
|
Acridine, 9-amino-4-methyl-
| 3548-10-5 |
|
Adenosine, 2-chloro-N-cyclopentyl-
| 37739-05-2 |
|
Adenosine, 2-chloro-2'-deoxy-
| 4291-63-8 |
|
Adenosine, 2-chloro-2',3'-dideoxy-
| 114849-58-0 |
|
Adenosine, N-(2-(5-chloro-1H-imidazol-4-yl)ethyl)-
| 114849-58-0 |
|
Adenosine, N-(2-(5-chloro-1H-indol-3-yl)ethyl)-
| 114849-58-0 |
|
Adenosine, 2-chloro-, 5'-sulfamate (ester)
| 66522-52-9 |
|
Adenosine, cyclic 3',5'-(hydrogenphosphate)-
| 60-92-4 |
|
Adenosine, cyclic 3',5'-(hydrogenphosphate), compd.with 1-deoxy-1-(methylamino)-D- glucitol (1:1)
| 113960-50-2 |
|
Adenosine, cyclic 3',5'-(hydrogenphosphate),mono(1-oxobutyl) deriv.
| 34675-98-4 |
|
Adenosine, cyclic 3',5'-(hydrogen phosphate)-,monosodium salt
| 37839-81-9 |
|
|